BMC Infectious Diseases (Feb 2020)

Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report

  • Lev Volkov,
  • Gilda Grard,
  • Pierre-Edouard Bollaert,
  • Guillaume A. Durand,
  • Aurélie Cravoisy,
  • Marie Conrad,
  • Lionel Nace,
  • Guilhem Courte,
  • Rémy Marnai,
  • Isabelle Leparc-Goffart,
  • Sébastien Gibot

DOI
https://doi.org/10.1186/s12879-020-4838-x
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background Yellow fever vaccine exists for over 80 years and is considered to be relatively safe. However, in rare cases it can produce serious neurotropic and viscerotropic complications. We report a case of a patient who presented both viscerotropic and neurological manifestations after yellow fever vaccination. Case presentation We describe the case of a 37 years old man who developed after the yellow fever vaccination a yellow fever vaccine-associated viscerotropic disease followed by acute uveitis. Prolonged detection of yellow fever RNA in blood and urine was consistent with yellow fever vaccine-associated adverse event. The final outcome was good, although with persistent fatigue over a few months. Conclusions Even if the yellow fever vaccine is relatively safe, physicians should be aware of its possible serious adverse effects.

Keywords